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Abstract
The recently identified type VI secretion system (T6SS) is implicated in the virulence of many Gram-negative bacteria.
Edwardsiella tarda is an important cause of hemorrhagic septicemia in fish and also gastro- and extra-intestinal infections in
humans. The E. tarda virulent protein (EVP) gene cluster encodes a conserved T6SS which contains 16 open reading frames.
EvpC is one of the three major EVP secreted proteins and shares high sequence similarity with Hcp1, a key T6SS virulence
factor from Pseudomonas aeruginosa. EvpC contributes to the virulence of E. tarda by playing an essential role in functional
T6SS. Here, we report the crystal structure of EvpC from E. tarda PPD130/91 at a 2.8 A ˚ resolution, along with functional
studies of the protein. EvpC has a b-barrel domain with extended loops. The b-barrel consists of 11 anti-parallel b-strands
with an a-helix located on one side. In solution, EvpC exists as a dimer at low concentration and as a hexamer at higher
concentration. In the crystal, the symmetry related EvpC molecules form hexameric rings which stack together to form a
tube similar to Hcp1. Structure based mutagenesis revealed that N-terminal negatively charged residues, Asp4, Glu15 and
Glu26, and C-terminal positively charged residues, Lys161, Lys162 and Lys163, played crucial roles in the secretion of EvpC.
Moreover, the localization study indicates the presence of wild type EvpC in cytoplasm, periplasm and secreted fractions,
whereas the N-terminal and C-terminal mutants were found mostly in the periplasmic region and was completely absent in
the secreted fraction. Results reported here provide insight into the structure, assembly and function of EvpC. Further, these
findings can be extended to other EvpC homologs for understanding the mechanism of T6SS and targeting T6SS mediated
virulence in Gram-negative pathogens.
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Introduction
Gram-negative bacteria use various secretion systems to
transport proteins across bacterial membranes. To date, at least
seven secretion systems are known in Gram-negative bacteria (type
I to VII secretion systems). The type VI secretion system (T6SS) is
a recently discovered protein transport complex which contributes
to bacterial pathogenesis [1–4]. T6SS was initially identified in
Vibrio cholerae and named IcmF associated homologous protein
(IAHP) cluster [5]. In 2006, Mekalanos group showed that the
IAHP gene clusters of V. cholerae and Pseudomonas aeruginosa were
involved in protein secretion [6] and Pukatzki et al., [7] renamed
this novel secretion system as T6SS.
T6SSs are present in animal and plant proteobacteria and play
an important role in the virulence of many human and animal
pathogens [2,3,4]. In silico analyses showed that T6SSs are found
in at least 92 bacterial genomes and can be divided into four to five
different phylogenetic groups [8]. Hallmarks of T6SSs include the
presence of an ortholog of IcmF, an AAA
+ ATPase and at least
two secreted proteins, namely hemolysin co-regulated protein
(Hcp) and valine glycine repeat protein (VgrG) [2,3,4,5]. Hcp
homologs are secreted through a functional T6SS, and act as
virulence factors in pathogens such as P. aeruginosa, V. cholerae, and
Edwardsiella tarda [7,6,9]. Hcp1 in P. aeruginosa is actively secreted in
lungs of infected cystic fibrosis patients and is likely to contribute to
pathogenesis [6]. The crystal structure of Hcp1 from P. aeruginosa
revealed that it can associate into hexameric rings that stack onto
each other to form a nanotube-like channel [6,10]. Another
common virulence factor secreted by T6SS is VgrG. It has a
trimeric phage tail spike like structure similar to that of the T4
phage gp5(3)-gp27(3) complex (PDB 2P5Z; [11]). It is proposed
that the VgrG protein might act as a membrane-puncturing device
to help deliver effectors into host cells [12].
E. tarda is a Gram-negative pathogen which is associated with
septicemia and fatal infections in a wide variety of animals
including fish and humans [13,14]. In humans, it causes gastro-
and extra-intestinal infections such as myonecrosis, bacteremia,
septic arthritis and wound infections [15]. Using a comparative
proteomics approach, we have previously identified two secretion
systems, namely type III secretion system (T3SS) and T6SS, from
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12910a fish isolate PPD130/91 [9,16,17,18]. In E. tarda, T3SS and T6SS
contributed to the replication rates inside gourami phagocytes and
virulence towards gourami fish. Thus, the putative T6SS in E.
tarda was initially named EVP (Edwardsiella tarda virulent protein).
A systematic deletion of the T6SS genes in E. tarda revealed that 13
out of 16 genes in the EVP cluster are essential for secretion of
T6SS substrates. Based on functional assays, we classified the EVP
(T6SS) proteins into three groups: (1) eleven intracellular
apparatus (non-secreted) proteins, (2) three secreted proteins, and
(3) two proteins which are not required for the T6SS-dependent
secretion. Secreted proteins of E. tarda T6SS include a Hcp
homolog EvpC, a VgrG homolog EvpI, and a novel protein EvpP
which is not commonly present in other T6SS clusters [9]. Our
previous functional studies showed that the major secreted protein
EvpC is a key member in the EVP system of E. tarda and the
secretion of EvpC is a critical step for the function of T6SS [9,17].
In this work, we focus on eliciting the secretion property of EvpC
from structural and functional aspects.
Here we report the crystal structure of EvpC at 2.8 A ˚ resolution
and studies on its oligomerization and secretion. Gel filtration and
analytical ultra centrifugation (AUC) analyses confirmed that the
oligomerization state of EvpC is concentration dependent. Further,
structure-guided mutagenesis, followed by functional studies,
demonstrated that N-terminal negatively charged residues, Asp4,
Glu15 and Glu26, and C-terminal positively charged residues,
K161, K162 and K163, are involved in secretion of EvpC. The
localization study on EvpC and its mutants in the cytoplasm,
periplasm and secreted fraction showed the presence of wild type
EvpC in all three regions, whereas the N-terminal triple mutant and
C-terminal mutant was predominantly found in the periplasmic
region and none in the secreted fraction. The structural basis for the
secretion of EvpC reported here can be extended to its homologs in
other pathogens and, subsequently, this will help to understand the
T6SS mechanism in Gram-negative bacteria.
Results
Overall structure
The structure of recombinant EvpC from E. tarda was solved by
molecular replacement using a dataset collected on an R-axis
rotating anode generator and refined to a 2.8 A ˚ resolution
(Table 1). The EvpC model consists of residues from Ala2 to
Lys163. There are two molecules in the asymmetric unit (Figure 1).
These two molecules are part of two hexameric rings which can be
generated using crystallographic symmetry. Each monomer of
EvpC consists mainly of a b-barrel domain, with extended loops
lying predominantly on one side of the b-barrel. The diameter of
the monomeric b-barrel is approximately 12 A ˚ consisting of 11
anti-parallel b-strands. In addition, an a-helix (Ala66 - Gln76) is
located on one side of the b-barrel. Residues Gly35 to Met53 form
an extended loop which protrudes approximately 20 A ˚ from the b-
barrel (Figure 1).
Homology with other Hcp1 family proteins
A search for topologically similar proteins within the PDB was
performed with the program DALI [19]. Significant structural
similarities were observed between EvpC and the proteins Hcp1
(PDB code 1y12; rmsd=1.6 A ˚ for 158 Ca atoms; 32% sequence
identity) and Hcp3 (coordinates recently deposited; not yet
described in the literature; PDB code 3HE1; rmsd=2.2 A ˚ for
130 Ca atoms; 17.7% sequence identity) from P. aeruginosa, most
notably the presence of an overall b-barrel architecture. Figure 2
shows the Ca superposition of EvpC, Hcp1 and Hcp3. Significant
differences are observed between Hcp3 and EvpC. Particularly,
several loops of Hcp3 are different in length and conformation,
compared to both Hcp1 and EvpC. The structure based sequence
alignment of EvpC with Hcp1 from P. aeruginosa, and sequence
alignment with other Hcp homologs from various representative
pathogenic bacterial species/strains is given in Figure 3. The
overall structural and sequence similarity between EvpC and
Hcp1 strongly suggest that EvpC is a member of the Hcp family of
proteins. Recently, Pell et. al, [20] (PDB 2K4Q) reported that the
Hcp-like proteins are structurally related to the major tail proteins
of enterobacteriophage lambda. The sequence identity of EvpC
with various homologous proteins from selected pathogenic
bacterial species is given in Table S1.
A BLAST search [21] with the sequence of EvpC revealed that
it has more than 100 homologs from various bacterial species or
strains. All of these homologs shares approximately 50% similarity
and ,35% sequence identity with EvpC (Figure S1). Sequence
conservation is spread throughout the molecule, particularly at the
N- and C-termini, as well as MDCAS and VAVS sequence motifs
in the middle of the protein. However, no functional studies are
available to reveal the importance of these conserved motifs.
Oligomerization
The oligomerization state of EvpC in solution was investigated
using AUC, dynamic light scattering (DLS) and gel filtration. AUC
analysis of the eluted protein (, 2 mg/ml) from the Ni-NTA
Table 1. Data Collection and Refinement Statistics.
Data collection
Space group P6
Cell dimensions
a, b, c (A ˚) 85.5, 85.5, 93.1
a, b, c (u) 90, 90, 120
Resolution range (A ˚) 50.0 - 2.8 (2.9 - 2.8)
aRsym 16.3(33.7)
I/sI 7.5
Completeness (%) 94.2(88.5)
Redundancy 7.1(3.4)
Refinement
Resolution (A ˚) 29 - 2.8
No. reflections 9074
bRwork/
cRfree 0.238/0.284
Number of atoms
Protein 2348
Water 71
B-factors
Protein 26.4
Water 26.8
R.m.s deviations
Bond lengths (A ˚) 0.009
Bond angles (u) 1.250
aRsym = S|Ii-,I.|/ S|Ii| where Ii is the intensity of the i
th measurement, and
,I. is the mean intensity for that reflection.
bRwork = S|Fobs -F calc|/S|Fobs| where Fcalc and Fobs are the calculated and
observed structure factor amplitudes, respectively.
cRfree = as for Rwork, but for 5.0% of the total reflections chosen at random and
omitted from refinement.
Values in parentheses correspond to the highest resolution shell.
doi:10.1371/journal.pone.0012910.t001
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weight of a dimeric (40 kDa) and hexameric (120 kDa) EvpC. The
hexamer is the predominant form of EvpC, which is further
evident from the c(M) values (Figure 4). Gel filtration of the
concentrated protein (.2 mg/ml) produced a single peak
corresponding to hexameric EvpC (Figure S2). At a low
concentration of EvpC (,0.8 mg/ml) gel filtration revealed two
species corresponding to the hexamer and a predominant dimeric
form (Figure S3). This observation is supported by AUC (data not
shown). DLS of concentrated EvpC (6 mg/ml) showed an
apparent molecular weight of 212 kDa corresponding to two
hexamers of EvpC. It should be noted that the molecular weight
estimated from DLS experiments may not be accurate. DLS
usually gives the particle size of the predominant species. Precise
determination of the molecular weight with DLS is extremely
difficult given that EvpC forms hexameric rings rather than
globular particles. Although concentration dependent oligomeri-
zation (dimer and hexamer) of EvpC was observed in solution, all
of our experiments showed that hexamer is the preferred
oligomeric form of EvpC. A head-to-head stacked hexameric ring
structure of EvpC can be observed in the crystal lattice (Figure 5A).
This stacked ring structure forms a tube with an outer diameter of
80 A ˚ and an inner diameter of 40 A ˚ (Figure 5B). In Hcp1, the
asymmetric unit consisted of 3 monomers and the hexameric ring
could be generated by 6-fold symmetry. These symmetry related
hexameric rings stacked in top-to-bottom fashion forming an
extended nanotube [10]. In EvpC the asymmetric unit consists of
two monomers and the 6-fold symmetry generated two hexameric
rings stacked in head-to-head fashion. We assume that this head-
to-head stacking might be a crystallographic artifact. Taken
together, the observed hexameric form of EvpC in solution and
the hexameric ring formation by the symmetry related EvpC
molecules in the crystal, we speculate that the tube formation by
EvpC is analogous to Hcp1 and functionally relevant.
N terminal negatively charged residues are critical for
EvpC secretion
EvpC homologous proteins from T6SS (such as Hcp) do not
contain classical signal peptides, indicating that they are not
secreted in a way similar to Sec or type II secretion systems
[22,23]. It has been suggested that T6SS may use a unique but
unknown mechanism to export its proteins, which probably cross
the bacterial cell membrane in a single step [24]. From the crystal
structure of EvpC, we have identified 6 negatively charged
residues in the first 26 amino acids that are clustered in the N-
terminal region (Figure 6A). Notably, a BLAST search showed the
presence of 3 to 7 negatively charged residues at the N-terminal
region of EvpC homologs. Three of these residues are conserved
among 50 homologs, suggesting the importance of this cluster
(Figure S1). In addition, we found that introducing a 6His tag at
the N-terminal of EvpC completely blocked its secretion
(Figure 7A). To investigate the importance of these negatively
charged residues in the N-terminal region of EvpC, a series of
EvpC single, double and triple site-directed mutants was created
by substituting D4, E15 and E26 with Ala (Table 2). Plasmids
Figure 1. Ribbon diagram of the two EvpC molecules of an asymmetric unit. The N- and C- termini are indicated. This figure and the
following figures in the paper were prepared using PyMol [40].
doi:10.1371/journal.pone.0012910.g001
Figure 2. Ca superposition of EvpC with homologue structures
Hcp1 and Hcp3. EvpCisinyellow,Hcp1incyanandHcp3isinbluecolor.
doi:10.1371/journal.pone.0012910.g002
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E. tarda DevpC mutant and their respective expression and secretion
of EvpC were anlaysed. The secretion of EvpC in various EvpC
mutants was similar to wild type (Figure S4), except for the triple
mutant D4A E15A E26A (Figure 7B), which seriously impaired
EvpC secretion in spite of having comparable growth rate with
that of the wild type bacteria carrying the intact evpC gene
(Figure 7B). The total cell protein profile (Figure 7B) confirmed the
expression of EvpC in this triple mutant suggesting that the
negatively charged residues D4, E15 and E26 together play a key
role only in the secretion of EvpC but not in its expression.
Role of C-terminal positively charged residues in EvpC
secretion
Positively charged amino acids have been shown to be
important in targeting proteins into secretory pathways and
facilitating protein secretion [25–27]. EvpC has a cluster of
positively charged residues located at the C-terminal region
(Figure 6B). In order to investigate the possible involvement of
these basic residues (K161, K162 and K163) in the secretion of
EvpC, we created the EvpC C-terminal deletion (EvpC M1-
N160) mutant. Subsequently, secretion assays were performed to
probe the impact of these residues on the secretion of T6SS
proteins, in particular EvpC. Western blot analysis showed that
thesecretion of EvpC was seriously impaired withthis C-terminal
deletion mutant (Figure 7B). The total cell protein profile
(Figure 7B) was comparable in the wild type as well as C-
terminal and N-terminal mutants which indicates that the
expression of EvpC was unaffected by these mutations. In
addition we have observed that there was a significant reduction
in the secretion of EvpP due to the C-terminal mutation
(Figure 8). These results strongly suggest that the positively
charged cluster of amino acids in the C-terminal region of EvpC
is important for the secretion of EvpC and EvpP.
Figure 3. Structural and sequence alignment of EvpC. First and second rows: Structure based sequence alignment of EvpC (PDB code 3EAA;
Q6EE19), Hcp1 (PDB code 1y12, Q9I747). Strictly conserved residues are shaded red with semi-conserved residues lettered in red. Three to eleven rows:
Suffix: Q6EE19: EvpC, E. tarda; Q9I747: Hcp1, Psuedomonas aeruginosa; A1JTM5: Hypothetical protein, Yersinia enterocolitica; Q88IB0: Hypothetical
protein, Pseudomonas putida; Q1QVA0: Hypothetical protein, Chromohalobacter salexigens; B1TM76: Type VI secretion system effector, Methylocella
silvestris; Q3ZV17: Hypothetical protein, Enterobacter sakazakii; Q63IH5: Hypothetical protein, Burkholderia pseudomallei; Q93IS3: Putative cytoplasmic
protein, Salmonella typhimurium; Q7AXY8: SciM protein, Salmonella enterica; B2H5W1: SciM protein, Burkholderia pseudomallei 1655. Residues of EvpC
mutated in these studies are denoted by asterisks. Sequence alignment was done by ClustalW [41] and the figure was prepared using ESPript [42].
doi:10.1371/journal.pone.0012910.g003
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exhibited any defect in the secretion of EseB and EseC, two
known secreted translocators in the T3SS (Figure 8). To further
v e r i f yt h ep r o p e r t i e so fE v p Cm u t a n t s ,w eh a v ee x p r e s s e d
double, triple and C-terminal deletion mutants of EvpC and
tested their oligomerization. Gel filtration experiments showed
that all of these mutants exhibit the same oligomeric form as wild
type EvpC (Figure S5).
Localization of EvpC
In order to verify the localization of EvpC we carried out
mechanical fractionation studies. Western blot analysis confirmed
the presence of wild type EvpC in the cytoplasm, periplasm and in
the secreted fractions, whereas in the N-terminal triple mutant and
C-terminal deletion mutant, EvpC was completely absent in the
secreted fraction (Figure 9). Notably in both of these mutants, EvpC
was predominantly localized in the periplasm which confirms the
Figure 4. Analytical ultra centrifugation profile of EvpC on the sample eluted (,2 mg/ml concentration) from the gel filtration
column (Hiload 16/60 Superdex 200). This shows a mixture of two oligomers. A small peak with an apparent molecular weight of 40 kDa (dimer)
and a larger peak around 120 kDa (hexamer).
doi:10.1371/journal.pone.0012910.g004
Figure 5. Hexameric EvpC generated by symmetry related molecules. (A) Ribbon representation of EvpC hexameric ring formed by the
symmetry related molecules. Diameter of the pore is approximately 40 A ˚. (B) Stacking of EvpC hexameric rings which form a tube-like architecture.
doi:10.1371/journal.pone.0012910.g005
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against DnaK (cytoplasmic marker) and MBP (periplasmic marker)
confirm that there was no cross-contamination between cytoplas-
mic, periplasmic and secreted fractions (Figure 9). The absence of
EvpCinthesecreted fractioninspite ofitsnormalexpression clearly
reveals a serious defect in the secretion of these mutants.
Discussion
Hcp homologs are the major secreted proteins of T6SS in many
Gram-negative bacteria including P. aeruginosa, S. enterica, V. cholera,
and E. tarda [2]. Mutations of Hcp homologs decrease the virulence
of pathogenic bacteria [7,6,17]. Thus, the role of Hcp homologs is
vital for the function of T6SS. However, the secretion and transport
mechanisms of Hcp homologs remain unknown. EvpC is essential
forafunctionalT6SSandplaysanimportantroleinthe virulenceof
E. tarda [9,17]. Deletion of EvpC leads to lower replication rates in
phagocytes and increased LD50 in blue gourami fish by two log
value [17]. The structure of EvpC reported here is similar to that of
Hcp1 from P. aeruginosa. Mougous et al [6] revealed the presence of
Hcp1 in the lungs of P. aeruginosa infected patients. Moreover, it has
been shown using the in vitro experiments that Hcp1 can be
assembled to form nanotube like structures, which contain upto 25
subunits and are around 100 nm in length [10]. In the case of
EvpC, symmetry related molecules forms hexameric rings and these
rings stacks to form nanotube-like structures.
Our studies on the oligomeric state of EvpC using gel filtration
and AUC demonstrate the presence of two oligomeric states. We
found that EvpC exists as a dimer at low concentrations and as a
hexamer at higher concentrations. Based on these findings we
speculate that the concentration-dependent oligomerization of
EvpC may have functional implications. EvpC may exist as dimers
after production, and subsequently is transported to the assembly
point during infection where a higher concentration of EvpC
might facilitate the formation of hexameric rings to constitute the
secretion apparatus.
Structure guided mutational studies showed that the N-terminal
negatively charged and C-terminal positively charged residues can
affect the secretion of EvpC. In addition, the presence of 6His tag
at the N-terminal of EvpC adversely affected its secretion, possibly
due to the interactions between the His-tag and these negatively
charged residues. The analysis of crystal structure confirms that all
these residues (D4, E15, E26, K161, K162 and K163) are exposed
on the outer rim of the EvpC hexameric ring which makes them
available for interaction with other proteins.
The secretion of EvpC was seriously impaired in both N-
terminal (D4AE15AE26A) and C-terminal mutants (Figure 7B).
The secretion of EvpP was considerably reduced in the C-terminal
mutant (EvpC M1-N160). On the other hand, no reduction in the
secretion of EvpP was observed in the N-terminal triple mutant
(Figure 8). This indicates that the N-terminal residues are only
important for the secretion of EvpC whereas the C-terminal
residues play a role in the secretion of EvpC as well as for other
T6SS proteins like EvpP. The total cell protein analysis showed
that the expression of C-terminal mutant and the N-terminal triple
mutant of EvpC was comparable to the wild type bacteria
suggesting that these mutants only cause defects in the secretion of
EvpC but not its expression (Figure 7B). Further the fractionation
studies confirmed this finding (Figure 9). We noticed an increased
amount of EvpC in the periplasm compared to the cytoplasm in
these mutants which can be attributed to the failure in secretion.
The mechanical fractionation studies suggest that the N-terminal
and C-terminal residues are involved in the transport of T6SS
proteins from the periplasm to the extracellular region. It has
been shown that the C-terminal region of Type IV and Type
V secretion system proteins are involved in protein secretion
[26–28]. Mougous et al [24] showed that the EvpC homolog, Hcp1
is temporarily localized in periplasm, where it assembles into
nanotubes (stacked hexamers) and may be associated with VgrG (a
EvpI homolog) at the tip to puncture the membrane and allow
tube extension outwards into the extracellular space [4,24]. We
previously reported that secretion of EvpC and EvpI are mutually
dependent and mutation of either one of them leads to the absence
of EvpP in the supernatant [9]. Based on our mechanical
fractionation study and secretion assay it is tempting to speculate
that the interactions between EvpC and EvpI might be disrupted
in these mutants causing the abolition of secretion. Notably, both
the N-terminal and C-terminal residues are exposed in the
hexameric tube of EvpC which makes them available for engaging
with other molecules (Figure 6A and 6B). Moreover our results
showed that none of these EvpC mutants showed any defect in the
secretion of T3SS proteins such as EseB and EseC (Figure 8). Thus
EvpC being one of the secreted proteins of T6SS does not seem to
cross-talk with secreted proteins involved in T3SS.
In conclusion, EvpC homologs are widely found among a
number of pathogenic bacterial species and represent a new class
Figure 6. Surface representation of EvpC hexameric ring. (A) Location of N-terminal negatively charged residues (red) (top view). (B) Location
of the surface exposed C-terminal residues (red) (side view). The residues targeted for the mutational studies are shown in red.
doi:10.1371/journal.pone.0012910.g006
Structure of EvpC & Secretion
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12910of secreted apparatus proteins. Understanding the role of EvpC
will provide a significant step forward in resolving the T6SS
mechanism. This study uncovers the critical role of negatively
charged N-terminal residues (Asp4 Glu15 and Glu26) and the C-
terminal positively charged residues in the secretion of EvpC.
Impairing the secretion of EvpC will decrease the virulence of the
pathogenic bacteria. This may lead to the development of novel
strategies to restrict the T6SS-containing pathogenic bacteria.
Materials and Methods
Plasmid and strain construction
The evpC gene was PCR-amplified from E. tarda genomic DNA
and cloned into a derivative of pET vector (pETM32) (Novagen)
or pSA10 vector. evpC mutant plasmids were derived from wild
type evpC from pSA-evpC and pET-evpC by site-directed mutagen-
esis using inverse PCR or overlap PCR techniques. Various pSA-
evpC mutant plasmids were used to transform E. tarda DevpC strain
to yield different EvpC expression strains. The bacterial strains
and plasmids used in this study are listed in Table 2.
Purification and crystallization
Plasmid DNA was used to transform E. coli BL21 and cells
grown in defined M9 medium [29] supplemented with 25 mg/L-
SelMet, at 37uC to 0.6 AU at OD600. One liter of culture was
induced with 100 mM IPTG and continued to grow at 20uC
overnight. Cells were then harvested by centrifugation (9000 g;
20 min, 4uC) and resuspended in 40 ml of lysis buffer (50 mM
Tris-HCl, pH 7.5, 0.2 M NaCl, 1 mM EDTA, 1% (w/v) Triton
X-100, 5% (w/v) glycerol, 2 mM DTT and one protease inhibitor
tablet (Roche Diagnostics)). The protein was purified in three
steps, using DEAE-Sepharose (Amersham Pharmacia), Ni-NTA
(Qiagen) and Gel Filtration (Superdex200) columns. The purified
protein was kept in a buffer consisting of 20 mM Tris-HCl
pH 7.5, 200 mM NaCl, 2 mM DTT, and 5%( w/v) glycerol.
Crystallization conditions for the protein were screened using
Index Screens (Hampton Research) using the hanging-drop vapor-
diffusion technique at 21uC. Crystallization drops containing 1 ml
protein solution (40 mg/ml) and 1 ml reservoir solution. Diffraction
quality crystals grew from a reservoir solution consisting of 0.2 M
Ammonium sulfate, 0.1 M Bis-Tris pH 6.5 and 25% Polyethylene
glycol 3350. Crystals belonged to the space group P6 with two
molecules in the asymmetric unit. The unit cell parameters were a=
85.5, b=85.5, c=93.1 A ˚ (Table 1) and the solvent content was
40% (Matthews constant 2.16 A ˚ 3/Da)[30].
Data collection, structure solution and refinement
Crystals were cryoprotected in the reservoir solution supple-
mented with 12.5% Polyethylene glycol 3350 and flash cooled
at 100K. A complete diffraction dataset were collected using
Rigaku X-ray generator mounted with an RAXIS IV
+ image
plate detector. The collected dataset was processed with
HKL2000 [31]. Structure was solved by molecular replacement
technique using PHASER program from the CCP4suite [32,33].
Hcp1 protein (pdb code 1Y12, sequence identity=32%) was
used as the search model. Model building was performed using
the O program [34] and refinement was carried out using Phenix
[35]. Finally 123 well-defined water molecules were added, and
refinement was continued until the R-value converged to 0.238
(Rfree=0.284) for reflections I.s (I) to 2.8 A ˚ resolution. The
model had good stereochemistry, with all residues within the
allowed regions of Ramachandran plot (Table 1) analysed by
PROCHECK [36]. The 2Fo-Fc electron density map is shown in
Figure S6.
Preparation of Cytoplasmic, Periplasmic and Secreted
protein fractions
Overnight cultures of E. tarda in DMEM were diluted 1:200 in
fresh DMEM and incubated for 24 hr at the indicated
temperatures. For isolation of ECPs (Extra-cellular proteins),
bacterial cells were stored from the culture by centrifugation
(5,5006g, 20 min, 4uC), and the supernatant was filtered through
a 0.22 mm pore size small-protein binding filter (Millipore). The
ECP fraction was isolated by trichloroacetic acid (TCA)
precipitation and the protein pellet was washed thrice with
220uC acetone and then air dried. Periplasmic proteins were
prepared by osmotic shock treatment as described in [37] with
modification. The stored cell pellets were resuspended in a 5 ml
buffer containing 20% sucrose with 20 mM of Tris-HCl pH 7.5
and Na,EDTA (1ST BASE). The osmotically fragile cells were
collected after a static incubation for 30 min at room temperature
by centrifugation at 13,000 g for 30 min. The cell pellet was then
resuspended in 2 ml distilled H2O( 4 uC) and incubated with gentle
agitation at 4uC for 30 min. The supernatant fraction referred to
as the periplasmic fraction was collected after a centrifuge of
13,000 g at 4uC for 30 min. After the extraction of periplasmic
protein, the residual cell pellets were sonicated to obtain
cytoplasmic proteins. Both the cytoplasmic and periplasmic
fractions were precipitated with TCA and the protein pellet was
Figure 7. Western blots of the expression and secretion of EvpC
from E.tarda. EvpC mutantsharboring pSA10-EvpC wild type andvarious
mutants used in our study. (A) DevpC expressing pSA-evpC and pSA-evpC-
6His. Expression (bottom panel) and secretion (toppanel). The secretion of
EvpCiscompletelyabolishedbyadding6His-tagattheN-terminusdespite
having similar expression level as wild type. (B) Expression (bottom panel)
and secretion (top panel) of EvpC in wild type, N-terminal and C-terminal
mutants of EvpC. 1. Wild type 2. DevpC 3. Devpc + evpC 4. Devpc + evpC
(D4AE15AE26A) 5. Devpc + evpC (M1-N160).
doi:10.1371/journal.pone.0012910.g007
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protein pellets of ECPs were solubilized in 20 ml of Ready Prep
reagent 3 (5 M urea, 2 M thiourea, 2% (w/v) CHAPS, 2% (w/v)
SB 3–10, 40 mM Tris, and 0.2% (w/v) Bio-Lyte 3/10 ampholyte
(Bio-Rad)) and was stored at 280uC until analysis. For the
cytoplasmic and periplasmic fractions, 100 ml of Ready Prep
reagent 3 were used to solubilize the proteins. The protein
concentration was determined by a Bio-Rad protein assay kit with
bovine serum albumin as the standard.
Western blot analysis
Proteins were separated on 12% SDS-polyacrylamide gels. For
Western analysis, proteins were transferred to PVDF membrane
with a semi-dry system and examined by using the SuperSignal
Table 2. The bacteria strains and plasmids used in this study.
Strain or plasmid Description Reference or source
Strains
PPD130/91 Wild-type Edwardsiella tarda, Kms, Colr. Amps Ling et al. (2000)
DevpC PPD130/91, in-frame deletion of evpC Srinivasa et al. (2004)
Plasmids
pSA10 pKK177-3 derivative, lacI, Amp
r S. Altuvia
pSAevpC pSA10 with evpC fragment This study
pSA6His-evpC pSA10 with evpC fragment and 6His tag at N terminus This study
pSAevpCD4A pSA10 with evpC fragment, D4 residue is substituted with Ala This study
pSAevpC E15A pSA10 with evpC fragment, E15 residue is substituted with Ala This study
pSAevpC E26A pSA10 with evpC fragment, E26 residue is substituted with Ala This study
pSAevpC D4AE15A pSA10 with evpC fragment, D4 and E15 residues are substituted with Ala This study
pSAevpC D4AE26A pSA10 with evpC fragment, D4 and E26 residues are substituted with Ala This study
pSAevpC E15AE26A pSA10 with evpC fragment, E15 and E26 residues are substituted with Ala This study
pSAevpC D4AE15AE26A pSA10 with evpC fragment, substitute residues D4, E15 and E26 residues are substituted with Ala This study
pSAevpC 1–160 pSA10 with evpC fragment, with K161K162K163 deletion This study
pETM pET32 derivative, Ampr Novagen
pETMevpC pETM with evpC fragment and 6His tag at C terminus, This study
pETMevpC D4AE15A pETM with evpC fragment and 6His tag at C terminus, D4 and E15 residues are substituted with Ala This study
pETMevpC D4AE26A pETM with evpC fragment and 6His tag at C terminus, D4 and E26 residues are substituted with Ala This study
pETMevpC E15AE26A pETM with evpC fragment and 6His tag at C terminus, E15 and E26 residues are substituted with Ala This study
doi:10.1371/journal.pone.0012910.t002
Figure 8. Secretion of EvpP, Ese-B and EseC in wild type, N-
terminal mutant and C-terminal mutant. 1. Wild type 2. DevpC 3.
Devpc + evpC 4. Devpc + evpC (D4AE15AE26A) 5. Devpc + evpC (M1-
N160). The western blot was probed with anti-EvpP, anti-EvpC, anti-
EseB and anti-EseC rabbit polyclonal antibodies.
doi:10.1371/journal.pone.0012910.g008
Figure 9. Western blot analysis of the localization of EvpC
using anti-EvpC antibody. (A) Wild type (B) N-terminal triple mutant
(C) C-terminal mutant (D) Periplasmic marker (E) Cytoplasmic marker.
EvpC is predominantly localized in the periplasmic space and is
secreted outside only by the wild type bacteria. 1. Cytoplasmic fraction
2. Periplasmic fraction 3. Secreted fraction. Anti-MBP Monoclonal
antibody (NEB) and Anti-DnaK Monoclonal antibody (Stressgen) were
used as periplasmic and cytoplasmic markers.
doi:10.1371/journal.pone.0012910.g009
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mended by the manufacturer (Pierce). EseB, EseC, EvpP and
EvpC were detected by the addition of diluted anti-EseB
(1:10000), anti-EseC (1:10000), anti-EvpP (1:5000) and anti-EvpC
(1:5000) polyclonal antisera, respectively, followed by a 1:5000
dilution of mouse anti-rabbit IgG HRP (Santa Cruz Biotechnol-
ogy). Anti-MBP Monoclonal antibody (NEB) and Anti-DnaK
Monoclonal antibody (Stressgen) were used as periplasmic and
cytoplasmic markers.
Dynamic light scattering (DLS)
DLS measurements were performed at room temperature on a
DynaPro (Protein Solutions) DLS instrument. The percentage of
polydispersity was 5% and the SOS error was 2.11 for the protein
sample at 6 mg/ml concentration. The quality of the data is
represented in the sum of squares (SOS) error statistic reported for
each sample acquisition (a single correlation curve).
Analytical Ultra Centrifugation (AUC)
The oligomeric state of EvpC was investigated by monitoring its
sedimentation properties in sedimentation velocity experiments.
500 ml of samples at 2.5 mg/ml in TRIS buffer (Tris-HCl 10 mM
pH 7.0, 200 mM NaCl) was used for these experiments. The
experiments were carried out in duplicates with the presence and
absence of DTT (21mM) in the buffer to find out the effect of
DTT in the oligomerization state. The sedimentation velocity
profiles were collected by monitoring the absorbance at 280 nm.
The samples were centrifuged at 40,000 rpm at 20uCi na
Beckman Optima XL-I centrifuge fitted with a six-hole AN-60
rotor and double-sector aluminum centerpieces and equipped with
absorbance optics. The scans were analysed using Sedfit program
[38].
Accession Number
Coordinates of EvpC have been deposited in the Protein Data
Bank (http://www.pdb.org) [39] under accession code 3EAA.
Supporting Information
Table S1 The sequence identity of EvpC with various
homologous proteins from selected pathogenic bacterial species.
Found at: doi:10.1371/journal.pone.0012910.s001 (0.03 MB
DOC)
Figure S1 Sequence alignment of EvpC and its homologues.
The alignment was performed using ClustalW [41], and this figure
was prepared using ESPript [42].
Found at: doi:10.1371/journal.pone.0012910.s002 (0.02 MB
PDF)
Figure S2 Gel filtration (Hiload16/60 Superdex 75 column)
profile of EvpC at a higher concentration (.2 mg/ml), the peak
corresponds to an apparent molecular weight of 120 KDa
(hexamer).
Found at: doi:10.1371/journal.pone.0012910.s003 (1.24 MB TIF)
Figure S3 Gel filtration (Hiload16/60 Superdex 75 column)
profile of EvpC at a low concentration (,0.8 mg/ ml) shows two
peaks. Peak 1 (small peak) corresponds to an apparent molecular
weight of 120 kDa (hexamer) and peak 2 corresponds to an
apparent molecular weight of 44 kDa (dimer).
Found at: doi:10.1371/journal.pone.0012910.s004 (0.11 MB TIF)
Figure S4 Western blots of the expression and secretion of EvpC
from E. tarda. DevpC expressing pSA-evpC and N terminus single
and double mutants of evpC. The western blot was probed with
anti-EvpC rabbit polyclonal antibodies.
Found at: doi:10.1371/journal.pone.0012910.s005 (0.07 MB TIF)
Figure S5 Gel filtration (Hiload16/60 Superdex 75 column)
profile of EvpC wild type and mutants at 2 mg/ml concentration
which shows a single peak around 120 kDa (hexameric EvpC).
Found at: doi:10.1371/journal.pone.0012910.s006 (0.05 MB TIF)
Figure S6 Stereo view of the final 2Fo-Fc electron density map.
This map is contoured at a level of 1.0 s. This figure was prepared
using PyMol [41].
Found at: doi:10.1371/journal.pone.0012910.s007 (2.55 MB TIF)
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